334 related articles for article (PubMed ID: 28987259)
1. Primary Sclerosing Cholangitis: What the Gastroenterologist and Hepatologist Needs to Know.
Gossard AA; Gores GJ
Clin Liver Dis; 2017 Nov; 21(4):725-737. PubMed ID: 28987259
[TBL] [Abstract][Full Text] [Related]
2. Cancer Risk and Surveillance in Primary Sclerosing Cholangitis.
Folseraas T; Boberg KM
Clin Liver Dis; 2016 Feb; 20(1):79-98. PubMed ID: 26593292
[TBL] [Abstract][Full Text] [Related]
3. Primary sclerosing cholangitis.
Karlsen TH; Schrumpf E; Boberg KM
Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):655-66. PubMed ID: 20955968
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of cholangiocarcinoma in primary sclerosing cholangitis.
Taghavi SA; Eshraghian A; Niknam R; Sivandzadeh GR; Bagheri Lankarani K
Expert Rev Gastroenterol Hepatol; 2018 Jun; 12(6):575-584. PubMed ID: 29781738
[TBL] [Abstract][Full Text] [Related]
5. Carcinoembryonic Antigen Level in Primary Sclerosing Cholangitis Is Not Influenced by Dominant Strictures or Bacterial Cholangitis.
Wannhoff A; Rupp C; Friedrich K; Knierim J; Flechtenmacher C; Weiss KH; Stremmel W; Gotthardt DN
Dig Dis Sci; 2017 Feb; 62(2):510-516. PubMed ID: 27943017
[TBL] [Abstract][Full Text] [Related]
6. Reporting standards for primary sclerosing cholangitis using MRI and MR cholangiopancreatography: guidelines from MR Working Group of the International Primary Sclerosing Cholangitis Study Group.
Venkatesh SK; Welle CL; Miller FH; Jhaveri K; Ringe KI; Eaton JE; Bungay H; Arrivé L; Ba-Ssalamah A; Grigoriadis A; Schramm C; Fulcher AS;
Eur Radiol; 2022 Feb; 32(2):923-937. PubMed ID: 34363134
[TBL] [Abstract][Full Text] [Related]
7. Elevated Serum Bilirubin Level Correlates With the Development of Cholangiocarcinoma, Subsequent Liver Transplantation, and Death in Patients With Primary Sclerosing Cholangitis.
Haseeb A; Siddiqui A; Taylor LJ; Cox K; Adler DG
J Clin Gastroenterol; 2016; 50(5):431-5. PubMed ID: 26927495
[TBL] [Abstract][Full Text] [Related]
8. Suspicious brush cytology is an indication for liver transplantation evaluation in primary sclerosing cholangitis.
Boyd S; Vannas M; Jokelainen K; Isoniemi H; Mäkisalo H; Färkkilä MA; Arola J
World J Gastroenterol; 2017 Sep; 23(33):6147-6154. PubMed ID: 28970730
[TBL] [Abstract][Full Text] [Related]
9. Colorectal cancer and cholangiocarcinoma in patients with primary sclerosing cholangitis and inflammatory bowel disease.
Manninen P; Karvonen AL; Laukkarinen J; Aitola P; Huhtala H; Collin P
Scand J Gastroenterol; 2015 Apr; 50(4):423-8. PubMed ID: 25636976
[TBL] [Abstract][Full Text] [Related]
10. Primary sclerosing cholangitis in children versus adults: lessons for the clinic.
Adike A; Carey EJ; Lindor KD
Expert Rev Gastroenterol Hepatol; 2018 Oct; 12(10):1025-1032. PubMed ID: 30199272
[TBL] [Abstract][Full Text] [Related]
11. Cholangiocarcinoma and its mimickers in primary sclerosing cholangitis.
Lee JJ; Schindera ST; Jang HJ; Fung S; Kim TK
Abdom Radiol (NY); 2017 Dec; 42(12):2898-2908. PubMed ID: 28951947
[TBL] [Abstract][Full Text] [Related]
12. Recent insights in primary sclerosing cholangitis.
Ponsioen CY
J Dig Dis; 2012 Jul; 13(7):337-41. PubMed ID: 22713082
[TBL] [Abstract][Full Text] [Related]
13. Cancer surveillance in patients with primary sclerosing cholangitis.
Razumilava N; Gores GJ; Lindor KD
Hepatology; 2011 Nov; 54(5):1842-52. PubMed ID: 21793028
[TBL] [Abstract][Full Text] [Related]
14. Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis (PSC): a Comprehensive Review.
Song J; Li Y; Bowlus CL; Yang G; Leung PSC; Gershwin ME
Clin Rev Allergy Immunol; 2020 Feb; 58(1):134-149. PubMed ID: 31463807
[TBL] [Abstract][Full Text] [Related]
15. Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategies.
Fung BM; Lindor KD; Tabibian JH
World J Gastroenterol; 2019 Feb; 25(6):659-671. PubMed ID: 30783370
[TBL] [Abstract][Full Text] [Related]
16. CA 19-9 and CEA are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis.
Björnsson E; Kilander A; Olsson R
Liver; 1999 Dec; 19(6):501-8. PubMed ID: 10661684
[TBL] [Abstract][Full Text] [Related]
17. Risk of hepato-pancreato-biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: A population-based cohort study.
Yu J; Refsum E; Helsingen LM; Folseraas T; Ploner A; Wieszczy P; Barua I; Jodal HC; Melum E; Løberg M; Blom J; Bretthauer M; Adami HO; Kalager M; Ye W
United European Gastroenterol J; 2022 Mar; 10(2):212-224. PubMed ID: 35107865
[TBL] [Abstract][Full Text] [Related]
18. FUT2 and FUT3 genotype determines CA19-9 cut-off values for detection of cholangiocarcinoma in patients with primary sclerosing cholangitis.
Wannhoff A; Hov JR; Folseraas T; Rupp C; Friedrich K; Anmarkrud JA; Weiss KH; Sauer P; Schirmacher P; Boberg KM; Stremmel W; Karlsen TH; Gotthardt DN
J Hepatol; 2013 Dec; 59(6):1278-84. PubMed ID: 23958938
[TBL] [Abstract][Full Text] [Related]
19. Primary sclerosing cholangitis and cholangiocarcinoma.
Lazaridis KN; Gores GJ
Semin Liver Dis; 2006 Feb; 26(1):42-51. PubMed ID: 16496232
[TBL] [Abstract][Full Text] [Related]
20. Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitis.
Jendrek ST; Gotthardt D; Nitzsche T; Widmann L; Korf T; Michaels MA; Weiss KH; Liaskou E; Vesterhus M; Karlsen TH; Mindorf S; Schemmer P; Bär F; Teegen B; Schröder T; Ehlers M; Hammers CM; Komorowski L; Lehnert H; Fellermann K; Derer S; Hov JR; Sina C
Gut; 2017 Jan; 66(1):137-144. PubMed ID: 27406039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
